StockpollyBeta
Get App
Popularity #3,095
CDXS · NASDAQ · Biotechnology

Codexis (CDXS)

Builds enzyme platforms for RNA manufacturing and pharma biocatalysis.

$1.39
After hours−0.02 (−1.07%)
At close$1.41(+1.81%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue92717813218159391515
Cost of revenue246344332334
Gross profit7221159185126361211
392223272525252525222023
Research & development141110111212131314111012
121113161413121211111011
Selling & marketing000000000000
General & administrative01100000000011
Other expenses1300000000000
Operating income−320−12−23−17−7−20−13−1914−8−11
−3−700−4−300−1−4−1−1
Interest income111111111111
Interest expense00015−6101000
Other non-operating income−1370−1−13−10−1411
Income before tax−35−7−11−23−21−10−21−13−2010−9−12
Income tax expense000000000000
Net income from continuing operations−35−7−12−23−21−10−21−13−2010−9−12
Net income−35−7−12−23−21−10−21−13−2010−9−12
EPS, basic−$0.50−$0.10−$0.16−$0.32−$0.29−$0.13−$0.25−$0.16−$0.22$0.11−$0.10−$0.13
EPS, diluted−$0.50−$0.10−$0.16−$0.32−$0.29−$0.13−$0.25−$0.16−$0.22$0.11−$0.10−$0.13
Weighted average shares, basic697070707281828590909191
Weighted average shares, diluted697070707281828590919191
EBITDA−16−5−9−20−14−8−18−11−1612−6−11
Depreciation & amortization222222222221
EBIT−19−7−11−22−16−10−20−13−1810−9−12